Trials / Not Yet Recruiting
Not Yet RecruitingNCT07032116
YiqiJiangzhuoHuoxueTongluo Method to Delay the Occurrence of End-stage Renal Disease in Diabetic Kidney Disease--Study1
Evidence-based Evaluation of Yiqi Jiangzhuo Huoxue Tongluo Method in Delaying the Occurrence of End-stage Renal Disease in Diabetic Kidney Disease--Study 1
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 4,472 (estimated)
- Sponsor
- Liu Hongfang · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
In order to reduce the clinical demand for kidney dialysis rate of Diabetic Kidney Disease(DKD) patients, a bidirectional cohort study of 4472 patients with DKD (Qi deficiency and collateral stasis syndrome) was carried out based on a preliminary DKD cohort of 13,000 patients. The exposure factor was supplementing and reducing the kidney turbidity-Huoxue Tongluo method represented by the addition and subversion of Shenzhuo prescription, and the incidence of end-stage renal disease was the main therapeutic index. Follow-up was conducted for 2 years
Conditions
Timeline
- Start date
- 2025-08-01
- Primary completion
- 2028-07-31
- Completion
- 2028-07-31
- First posted
- 2025-06-22
- Last updated
- 2025-06-22
Locations
5 sites across 1 country: China
Source: ClinicalTrials.gov record NCT07032116. Inclusion in this directory is not an endorsement.